Section b3 date of event is being reported as (b)(6) 2022, the date bwi received information about the patient's procedure.However, no information to confirm the exact date was reported, therefore, (b)(6) 2022 is the approximate event date.Device evaluation details: visual analysis revealed that the hemostatic valve was dislodged inside the hub component.Microscopic examination of the hemostatic valve surface showed stress marks on the outer diameter.The damage observed could be related to the incorrect insertion of the dilator into the sheath causing the dislodgment of the valve; the stress marks and physical damage observed suggest that excessive force or manipulation was applied; however, this could not be conclusively determined.The dilator was inspected, and it was found in normal condition.The valve is related to the obstruction reported by the customer.Device history record evaluation was performed for the finished device 00002099 number, and no internal actions related to the reported complaint condition were identified.The issue reported by the customer was confirmed.The odp (optimal device performance guide) contains the following caution: always insert a dilator straight into the center of the sheath¿s valve to prevent damage to the valve.Do not insert a dilator at an angle, as damage to the sheath valve may occur.As part of the quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|